DE69500198T2 - Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen - Google Patents

Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen

Info

Publication number
DE69500198T2
DE69500198T2 DE69500198T DE69500198T DE69500198T2 DE 69500198 T2 DE69500198 T2 DE 69500198T2 DE 69500198 T DE69500198 T DE 69500198T DE 69500198 T DE69500198 T DE 69500198T DE 69500198 T2 DE69500198 T2 DE 69500198T2
Authority
DE
Germany
Prior art keywords
production
pharmaceutical preparations
preparations containing
cns agents
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69500198T
Other languages
English (en)
Other versions
DE69500198D1 (de
Inventor
Ges Jose Maria Caldero
Clotet Huguet
Olondriz Francisco Marquillas
Barjoan Pere Dalmases
Rovira Anna Bosch
Acin Joan Roca
Nieto Juan Carlos Del Castillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Application granted granted Critical
Publication of DE69500198D1 publication Critical patent/DE69500198D1/de
Publication of DE69500198T2 publication Critical patent/DE69500198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
DE69500198T 1994-02-24 1995-02-02 Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen Expired - Fee Related DE69500198T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09400362A ES2085234B1 (es) 1994-02-24 1994-02-24 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
PCT/ES1995/000015 WO1995023144A1 (es) 1994-02-24 1995-02-02 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Publications (2)

Publication Number Publication Date
DE69500198D1 DE69500198D1 (de) 1997-04-30
DE69500198T2 true DE69500198T2 (de) 1997-10-16

Family

ID=8285331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69500198T Expired - Fee Related DE69500198T2 (de) 1994-02-24 1995-02-02 Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen

Country Status (12)

Country Link
US (1) US5658916A (de)
EP (1) EP0695751B1 (de)
JP (1) JP2848707B2 (de)
AT (1) ATE150752T1 (de)
AU (1) AU677146B2 (de)
CA (1) CA2160717A1 (de)
DE (1) DE69500198T2 (de)
DK (1) DK0695751T3 (de)
ES (2) ES2085234B1 (de)
GR (1) GR3023800T3 (de)
RU (1) RU2126005C1 (de)
WO (1) WO1995023144A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138908B1 (es) * 1997-08-14 2000-09-16 Vita Invest Sa Polimorfos de la 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-il) 3,6. dihidro-2h-piridin-1-il)-etil)-2-metil-6,7,8,9-tetrahidropirido (1,2-a) pirimidin-4-ona y procedimientos para su obtencion.
ES2141671B1 (es) * 1997-12-26 2001-01-01 Vita Invest Sa Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
HU227118B1 (en) * 2001-11-13 2010-07-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
US8314110B2 (en) * 2007-04-19 2012-11-20 Youxin Li Compounds for treating mental disorders, and preparation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
KR910000165B1 (ko) * 1985-03-27 1991-01-21 쟈안센 파아마슈우티카 엔. 부이. 1,2-벤즈이소옥사졸-3-일과 1,2-벤즈이소티아졸-3-일 유도체의 제조방법
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones

Also Published As

Publication number Publication date
AU677146B2 (en) 1997-04-10
US5658916A (en) 1997-08-19
AU1538195A (en) 1995-09-11
EP0695751B1 (de) 1997-03-26
RU2126005C1 (ru) 1999-02-10
JP2848707B2 (ja) 1999-01-20
CA2160717A1 (en) 1995-08-31
EP0695751A1 (de) 1996-02-07
DE69500198D1 (de) 1997-04-30
JPH08509505A (ja) 1996-10-08
GR3023800T3 (en) 1997-09-30
DK0695751T3 (da) 1997-09-29
ES2085234B1 (es) 1997-01-16
ATE150752T1 (de) 1997-04-15
WO1995023144A1 (es) 1995-08-31
ES2085234A1 (es) 1996-05-16
ES2100768T3 (es) 1997-06-16

Similar Documents

Publication Publication Date Title
EG19358A (en) Process for preparing of new n- aryl and n- heteroaryla-mide and urea derivatives as inhibitors of acyl coenzymes a: cholesterol acyl transferase ( A C A T )
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
IE890906L (en) Method of lowering the blood pressure
DE69332504T2 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
ATE246180T1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
ATE266663T1 (de) Acrylamid-derivate und verfahren zu deren herstellung
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
DE3785878T2 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
ATE253577T1 (de) Neue wasserlösliche fluoroethylcamptothecin- derivate und ein verfahren zu ihrer herstellung
DE69500198T2 (de) Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen
DE3774273D1 (de) Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
ATE165822T1 (de) Chinolin-4-carbonylguanidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU655869B2 (en) An amphoteric tricyclic compound
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
IT1276738B1 (it) Processo per la preparazione di derivati dell'acido -metil-2- tiofeneacetico
ATE173734T1 (de) Heteroarenylpiperazine, verfahren zu ihrer herstellung und ihre anwendung als medikamente
ATE170188T1 (de) 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament
ES8704163A1 (es) Un procedimiento para preparar derivados de cefem.
FI970452A (fi) Leukotrieenin biosynteesin estäminen ureajohdannaisten avulla
GR3002688T3 (en) Thiadiazolylacetamide derivatives, process for the preparation thereof and their use
EP0757040A4 (de) Adamantan-derivate, verfahren zu deren herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee